Impact of Community-Wide Tuberculosis Active Case Finding and Human Immunodeficiency Virus Testing on Tuberculosis Trends in Malawi.
HIV
active case finding
epidemiology
tuberculosis
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
05 07 2023
05 07 2023
Historique:
received:
21
10
2022
medline:
6
7
2023
pubmed:
26
4
2023
entrez:
26
4
2023
Statut:
ppublish
Résumé
Tuberculosis case-finding interventions are critical to meeting World Health Organization End TB strategy goals. We investigated the impact of community-wide tuberculosis active case finding (ACF) alongside scale-up of human immunodeficiency virus (HIV) testing and care on trends in adult tuberculosis case notification rates (CNRs) in Blantyre, Malawi. Five rounds of ACF for tuberculosis (1-2 weeks of leafleting, door-to-door enquiry for cough and sputum microscopy) were delivered to neighborhoods ("ACF areas") in North-West Blantyre between April 2011 and August 2014. Many of these neighborhoods also had concurrent HIV testing interventions. The remaining neighborhoods in Blantyre City ("non-ACF areas") provided a non-randomized comparator. We analyzed TB CNRs from January 2009 until December 2018. We used interrupted time series analysis to compare tuberculosis CNRs before ACF and after ACF, and between ACF and non-ACF areas. Tuberculosis CNRs increased in Blantyre concurrently with start of ACF for tuberculosis in both ACF and non-ACF areas, with a larger magnitude in ACF areas. Compared to a counterfactual where pre-ACF CNR trends continued during ACF period, we estimated there were an additional 101 (95% confidence interval [CI] 42 to 160) microbiologically confirmed (Bac+) tuberculosis diagnoses per 100 000 person-years in the ACF areas in 3 and a half years of ACF. Compared to a counterfactual where trends in ACF area were the same as trends in non-ACF areas, we estimated an additional 63 (95% CI 38 to 90) Bac + diagnoses per 100 000 person-years in the same period. Tuberculosis ACF was associated with a rapid increase in people diagnosed with tuberculosis in Blantyre.
Sections du résumé
BACKGROUND
Tuberculosis case-finding interventions are critical to meeting World Health Organization End TB strategy goals. We investigated the impact of community-wide tuberculosis active case finding (ACF) alongside scale-up of human immunodeficiency virus (HIV) testing and care on trends in adult tuberculosis case notification rates (CNRs) in Blantyre, Malawi.
METHODS
Five rounds of ACF for tuberculosis (1-2 weeks of leafleting, door-to-door enquiry for cough and sputum microscopy) were delivered to neighborhoods ("ACF areas") in North-West Blantyre between April 2011 and August 2014. Many of these neighborhoods also had concurrent HIV testing interventions. The remaining neighborhoods in Blantyre City ("non-ACF areas") provided a non-randomized comparator. We analyzed TB CNRs from January 2009 until December 2018. We used interrupted time series analysis to compare tuberculosis CNRs before ACF and after ACF, and between ACF and non-ACF areas.
RESULTS
Tuberculosis CNRs increased in Blantyre concurrently with start of ACF for tuberculosis in both ACF and non-ACF areas, with a larger magnitude in ACF areas. Compared to a counterfactual where pre-ACF CNR trends continued during ACF period, we estimated there were an additional 101 (95% confidence interval [CI] 42 to 160) microbiologically confirmed (Bac+) tuberculosis diagnoses per 100 000 person-years in the ACF areas in 3 and a half years of ACF. Compared to a counterfactual where trends in ACF area were the same as trends in non-ACF areas, we estimated an additional 63 (95% CI 38 to 90) Bac + diagnoses per 100 000 person-years in the same period.
CONCLUSIONS
Tuberculosis ACF was associated with a rapid increase in people diagnosed with tuberculosis in Blantyre.
Identifiants
pubmed: 37099318
pii: 7143198
doi: 10.1093/cid/ciad238
pmc: PMC10320183
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
94-100Subventions
Organisme : Medical Research Council
ID : MR/P022081/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 091769/Z/10/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203905/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206575/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200901/Z/16/Z
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
PLoS One. 2018 Dec 26;13(12):e0209098
pubmed: 30586448
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Lancet. 2013 Oct 5;382(9899):1183-94
pubmed: 23915882
Am J Epidemiol. 2013 May 15;177(10):1143-7
pubmed: 23589586
PLOS Glob Public Health. 2021 Dec 8;1(12):e0000088
pubmed: 36962123
Int J Tuberc Lung Dis. 2021 Dec 1;25(12):964-973
pubmed: 34886925
JAMA. 2014 Jul 23-30;312(4):372-9
pubmed: 25038356
Int J Epidemiol. 2018 Dec 1;47(6):2082-2093
pubmed: 29982445
Int J Tuberc Lung Dis. 2010 Jun;14(6):720-6
pubmed: 20487610
Bull World Health Organ. 2019 Jun 01;97(6):405-414
pubmed: 31210678
PLoS One. 2009;4(5):e5443
pubmed: 19424460
Am J Epidemiol. 2019 Jun 1;188(6):1155-1164
pubmed: 30824911
BMC Med. 2019 Jan 29;17(1):21
pubmed: 30691470
Bull World Health Organ. 2006 Feb;84(2):112-9
pubmed: 16501728
Am J Epidemiol. 2016 Jan 15;183(2):156-66
pubmed: 26646292
Lancet Public Health. 2021 May;6(5):e283-e299
pubmed: 33765456
J Int AIDS Soc. 2021 Sep;24 Suppl 5:e25788
pubmed: 34546657
Int J Tuberc Lung Dis. 2016 Aug;20(8):1014-21
pubmed: 27393533
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
S Afr Med J. 2021 Apr 06;111(5):402-404
pubmed: 34852877
Int J Tuberc Lung Dis. 2021 Mar 1;25(3):171-181
pubmed: 33688805
Lancet. 2010 Oct 9;376(9748):1244-53
pubmed: 20923715